These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8094628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J.
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
    Hesslinger B, Normann C, Langosch JM, Klose P, Berger M, Walden J.
    J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic effects on serine and glycine metabolism.
    Baruah S, Waziri R, Sherman A.
    Biol Psychiatry; 1993 Oct 15; 34(8):544-50. PubMed ID: 7903868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec 15; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 13. Lowest effective dose of depot neuroleptics.
    Hoencamp E, Haffmans PJ, Jansen GS.
    Br J Psychiatry; 1992 Mar 15; 160():422-3. PubMed ID: 1348655
    [No Abstract] [Full Text] [Related]

  • 14. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B, Buchanan RW, Maeda K, Carpenter WT, Jauch D, Tamminga CA.
    Biol Psychiatry; 1989 Jun 15; 26(2):131-8. PubMed ID: 2567610
    [Abstract] [Full Text] [Related]

  • 15. Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression.
    Gitlin MJ, Nuechterlein KH, Mintz J, Fogelson D, Bartzokis G, Ventura J, Subotnik K, Aravagiri M.
    Psychopharmacology (Berl); 2000 Mar 15; 148(4):350-4. PubMed ID: 10928306
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.
    Encephale; 1995 Mar 15; 21(6):417-24. PubMed ID: 8674466
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.